Evaxion Biotech AS (NAS:EVAX)
$ 2.42 -0.08 (-3.2%) Market Cap: 13.50 Mil Enterprise Value: 16.44 Mil PE Ratio: 0 PB Ratio: 242.00 GF Score: 19/100

Q2 2022 Evaxion Biotech A/S Earnings Call Transcript

Aug 10, 2022 / 12:30PM GMT
Release Date Price: $27.8 (-0.71%)
Operator

Good morning, and welcome to the Evaxion Biotech Second Quarter 2022 Earnings Call. (Operator Instructions) After today's presentation, there will be an opportunity to ask questions. (Operator Instructions) Please note that this event is being recorded.

I would now like to turn the conference over to Corey Davis. Please go ahead.

Corey Davis

Thanks, Joe, and hello, everyone. Thanks for joining us this morning. Let me quickly remind everyone that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Because forward-looking statements involve risks and uncertainties, they're not guarantees of future performance and actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of factors, including those risk factors discussed in the company's annual report on Form 20-F filed on March 31, 2022 and the company's current and future reports filed with or submitted to the Securities and Exchange

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot